Parkinson's disease: The quintessential neuropsychiatric disorder

Weintraub, Daniel; Burn, David J.

doi:10.1002/mds.23664

Cited by 423

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Parkinson's disease: The quintessential neuropsychiatric disorder

Open access

Weintraub, Daniel, Burn, David J.·2011·Movement Disorders

DOI 10.1002/mds.23664

Open this paper in CoChat — free account

Abstract

Although diagnosed by characteristic motor features, Parkinson's disease may be preceded, and is frequently accompanied by, a wide range of cognitive and neuropsychiatric features. In addition to the most commonly studied disorders of dementia, depression, and psychosis, other relatively common and clinically significant psychiatric complications include impulse control disorders, anxiety symptoms, disorders of sleep and wakefulness, and apathy. These problems may be underrecognized and are frequently undertreated. The emergent focus on nonmotor aspects of Parkinson's disease over the past quarter of a century is highlighted by a nonlinear increase in the number of articles published devoted to this topic. Although the development of newer antidepressants, atypical antipsychotics, and cholinesterase inhibitors in recent years has had a positive benefit on the management of these troublesome and distressing symptoms, responses are frequently suboptimal, and this remains an area of major unmet therapeutic need. © 2011 Movement Disorder Society

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/mds.23664

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citation
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment
Mayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166
Enhanced or Impaired Cognitive Function in Parkinson's Disease as a Function of Dopaminergic Medication and Task Demands
Cools, R. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1136 · Cited by 906
Risk of dementia in Parkinson’s disease: A community-based, prospective study
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721
Non-recognition of depression and other non-motor symptoms in Parkinson's disease
Shulman, L. M., Taback, R. L., Rabinstein, A. A., & Weiner, W. J. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00015-3 · Cited by 695
Association of dopamine agonist use with impulse control disorders in Parkinson disease
Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., Moberg, P. J., & Stern, M. B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.969 · Cited by 662 · cited 1×
“As patients may not report such behaviors to a treating physician, either because of embarrassment and not suspecting an association with PD treatment or ambivalence regarding ceasing the behavior or treatment, ICDs remain generally underrecognized in clinical practice.(119) In a recent large multisite observational s…”
BackgroundSelf-citation
Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642
Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G. (2009) · Neurology · doi:10.1212/01.wnl.0000338632.00552.cb · Cited by 625

Show all 20 references

Research works printed but not linked: 167

10.1212/WNL.0b013e3181ff96dd · DOI
10.1007/s004150050455 · DOI
10.1037/0894-4105.11.1.44 · DOI
10.1016/S0028-3932(02)00257-9 · DOI · Paper page
10.1212/WNL.0b013e3181f39d0e · DOI · Paper page
Weintraub D, 2004, Evidence for both impaired encoding and retrieval memory profiles in Parkinson's disease, Cogn Behav Neurol, 17, 195
10.1001/archneur.60.3.387 · DOI · Paper page
10.1002/mds.20974 · DOI · Paper page
10.1111/j.1468-1331.2009.02707.x · DOI · Paper page
10.1002/mds.22384 · DOI
10.1212/01.wnl.0000278114.14096.74 · DOI · Paper page
10.1002/ana.410340412 · DOI
10.1212/01.WNL.0000031426.21683.E2 · DOI · Paper page
10.1212/WNL.0b013e3181bf992f · DOI
10.1093/brain/awp245 · DOI · Paper page
10.1136/jnnp.55.5.377 · DOI · Paper page
10.1212/WNL.54.10.1916 · DOI · Paper page
10.1007/s00401-003-0705-2 · DOI · Paper page
10.1002/ana.20635 · DOI · Paper page
10.1007/s007020200027 · DOI · Paper page
10.1212/WNL.0b013e3181f39a78 · DOI · Paper page
10.1212/WNL.0b013e3181b0bd3d · doi:10.1212/wnl.0b013e3181b0bd3d
10.1016/S0149-7634(02)00065-9 · DOI · Paper page
10.1001/archneur.57.4.470 · DOI · Paper page
10.1007/s007020050025 · DOI
10.1212/WNL.43.5.986 · DOI · Paper page
10.1007/s00415-005-0756-5 · DOI
10.1093/brain/awm313 · DOI · Paper page
10.1159/000153432 · DOI
10.1093/brain/awh088 · DOI · Paper page
10.3174/ajnr.A1556 · DOI · Paper page
10.3174/ajnr.A0850 · DOI · Paper page
10.1016/j.neuroimage.2006.09.003 · DOI · Paper page
10.1002/mds.21844 · DOI · Paper page
10.1002/mds.22007 · DOI · Paper page
10.1016/j.parkreldis.2007.06.008 · DOI · Paper page
10.1212/01.WNL.0000091864.39702.1C · DOI · Paper page
10.1212/WNL.0b013e3181c34b47 · DOI · Paper page
10.1056/NEJMoa041470 · DOI · Paper page
10.1016/S1474-4422(09)70146-2 · DOI · Paper page
10.1016/S1474-4422(10)70194-0 · DOI · Paper page
10.1136/bmj.320.7245.1287 · DOI
10.1001/archneur.1996.00550020087019 · DOI · Paper page
10.1002/mds.870130109 · DOI · Paper page
10.1002/mds.21803 · DOI · Paper page
10.1097/00005053-199001000-00005 · DOI · Paper page
10.1034/j.1600-0447.2002.02045.x · DOI
10.1176/jnp.8.1.20 · DOI
10.1002/mds.1042 · DOI · Paper page
10.1001/archneur.56.5.595 · DOI · Paper page
10.1212/01.WNL.0000129843.15756.A3 · DOI · Paper page
10.1016/S0167-4943(00)00087-X · DOI
10.1177/0891988704267456 · DOI
10.1176/appi.neuropsych.15.1.74 · DOI
10.1111/j.1600-0447.1994.tb01558.x · DOI
10.1002/mds.22130 · DOI
10.1177/089198879000300102 · DOI
10.1176/jnp.6.2.165 · DOI
10.1001/archneur.1997.00550170097020 · DOI · Paper page
10.1002/mds.23092 · DOI
10.1136/jnnp.2008.152983 · DOI
10.1002/mds.21765 · DOI · Paper page
10.1016/j.neuroimage.2009.04.059 · DOI
10.1016/j.jns.2009.08.027 · DOI
10.1176/appi.neuropsych.13.2.222 · doi:10.1176/appi.neuropsych.13.2.222
10.1007/s00259-008-0979-7 · DOI
Weintraub D, 2005, Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease, J Nucl Med, 46, 227
10.1007/s00213-010-1867-y · DOI
10.1002/mds.21333 · DOI · Paper page
10.1002/mds.20723 · DOI · Paper page
10.1016/j.parkreldis.2008.01.016 · DOI
10.1177/0891988703256053 · DOI · Paper page
10.1212/WNL.49.4.1168 · DOI · Paper page
10.1002/mds.21966 · DOI · Paper page
10.1212/01.wnl.0000336340.89821.b3 · DOI · Paper page
10.1080/08039489850139049 · DOI
10.1002/gps.865 · DOI
10.1016/S1474-4422(10)70106-X · DOI · Paper page
10.1002/mds.23270 · DOI · Paper page
10.1002/mds.21455 · DOI · Paper page
10.1212/01.wnl.0000191325.31068.c4 · DOI · Paper page
10.1001/archneurol.2010.166 · DOI · Paper page
10.1002/mds.22839 · DOI · Paper page
10.1212/WNL.55.2.281 · DOI · Paper page
10.1002/mds.20582 · DOI · Paper page
10.1080/09540260020002541 · DOI
10.1001/archneur.1996.00550120077019 · DOI · Paper page
Wolters ECh, 1999, Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment, Neurology, 52, S10
10.1007/PL00007822 · DOI
10.1093/brain/awp166 · DOI
10.1002/mds.22919 · DOI
10.1002/mds.22258 · DOI
10.1001/archneur.64.7.984 · DOI
10.1002/mds.22873 · DOI
10.1136/jnnp.2009.179655 · DOI
10.1002/mds.21875 · DOI · Paper page
10.1136/jnnp.2008.153163 · doi:10.1136/jnnp.2008.153163
10.1212/WNL.56.suppl_5.S1 · DOI · Paper page
10.1002/mds.20474 · DOI · Paper page
10.1002/mds.21116 · DOI · Paper page
10.2147/NDT.S5335 · DOI
10.1056/NEJM199903113401003 · DOI · Paper page
10.1016/S0140-6736(99)00860-0 · DOI · Paper page
10.1038/npp.2009.176 · DOI · Paper page
10.1001/archneur.64.8.1089 · DOI · Paper page
10.1001/archneurol.2010.65 · DOI · Paper page
10.1002/ana.22164 · DOI · Paper page
10.1136/jnnp.68.4.423 · DOI · Paper page
10.1002/mds.20045 · DOI · Paper page
10.1002/mds.21296 · DOI
10.1007/s00213-009-1697-y · DOI · Paper page
10.1038/npp.2010.84 · DOI · Paper page
10.1002/mds.22472 · DOI
10.1016/j.nbd.2010.03.013 · DOI · Paper page
10.1016/j.neuron.2009.12.027 · DOI · Paper page
10.1002/mds.23147 · DOI
10.1002/mds.21770 · DOI · Paper page
10.1001/archneurol.2009.294 · DOI · Paper page
10.1002/mds.21098 · DOI · Paper page
10.1136/jnnp.2006.102061 · DOI · Paper page
10.1002/ana.22029 · DOI · Paper page
10.2165/00002512-200219100-00002 · DOI
10.1002/mds.22868 · DOI · Paper page
10.1212/WNL.0b013e3181ec7fac · DOI · Paper page
10.1136/jnnp.51.4.540 · DOI · Paper page
10.1093/brain/123.6.1155 · DOI · Paper page
10.1212/WNL.62.5_suppl_2.S9 · DOI
10.1002/1531-8257(199911)14:6<922::AID-MDS1003>3.0.CO;2-7 · DOI · Paper page
10.1212/01.wnl.0000324862.29733.69 · DOI · Paper page
10.1002/1531-8257(199903)14:2<237::AID-MDS1006>3.0.CO;2-X · DOI
10.1001/jama.287.4.455 · DOI · Paper page
10.1016/j.sleep.2005.04.004 · DOI · Paper page
10.1007/s00415-006-0390-x · DOI · Paper page
10.1002/mds.23168 · DOI
10.1136/jnnp.2005.065870 · DOI · Paper page
10.1002/mds.10390 · DOI · Paper page
Hogl B, 2002, Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double‐blind, randomized, crossover, placebo‐controlled polygraphic trial, Sleep, 25, 62, 10.1093/sleep/25.8.62 · DOI · Paper page
10.1097/WNF.0b013e3181aa916a · DOI
10.1002/mds.21656 · DOI
10.1002/mds.20963 · DOI · Paper page
10.1002/mds.21551 · DOI · Paper page
10.1016/S1474-4422(06)70475-6 · DOI · Paper page
10.1016/S1474-4422(08)70114-5 · DOI · Paper page
10.1001/jama.2008.929 · DOI · Paper page
10.1093/brain/awp315 · DOI · Paper page
10.1056/NEJMoa060281 · DOI · Paper page
10.1056/NEJMoa0907083 · DOI · Paper page
10.1093/brain/awn214 · DOI · Paper page
Richard IH, 2001, Relationship between mood and motor fluctuations in Parkinson's disease, J Neuropsychiatry Clin Neurosci, 13, 35, 10.1176/jnp.13.1.35 · DOI
10.1002/mds.21205 · DOI
10.1002/mds.870100316 · DOI
10.1176/jnp.8.4.383 · DOI · Paper page
10.1002/mds.22221 · DOI
10.1002/mds.22833 · DOI · Paper page
10.1002/mds.870120607 · DOI · Paper page
10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5 · DOI · Paper page
10.1176/jnp.4.2.134 · DOI · Paper page
10.1002/mds.22577 · DOI
10.1212/01.wnl.0000230572.07791.22 · DOI · Paper page
10.1002/mds.10041 · DOI · Paper page
10.1002/mds.23268 · DOI · Paper page
10.1093/brain/awq032 · DOI · Paper page
10.1097/JGP.0b013e3181b215ec · DOI
10.1136/jnnp.2008.166629 · DOI
10.1002/mds.21596 · DOI · Paper page
10.1002/mds.21696 · DOI
Ponce FA, 2010, The most cited works in Parkinson's disease, Mov Disord

Parkinson disease
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
“The high prevalence of cognitive impairment and protean psychiatric complications has changed how we conceptualize PD.(47,48) This has manifested itself in the recently proposed revised clinical diagnostic criteria,(17,49) which allows for dementia to be a comorbid condition at the time of diagnosis.”
Self-citation
Parkinson’s Disease
Mhyre, T. R., Boyd, J. T., Hamill, R. W., & Maguire-Zeiss, K. A. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-5416-4_16 · Cited by 423
Caregiver Burden in Parkinson Disease: A Critical Review of Recent Literature
Mosley, P. E., Moodie, R., & Dissanayaka, N. (2017) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988717720302 · Cited by 292
Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours
Lhommée, E., Klinger, H., Thobois, S., Schmitt, E., Ardouin, C., Bichon, A., Kistner, A., Fraix, V., Xie, J., Aya Kombo, M., et al. (2012) · Brain · doi:10.1093/brain/aws078 · Cited by 296

See all 423

Authors: Weintraub, D., & Burn, D. J.
Venue: Movement Disorders
Publisher: Wiley
Published: 2011-05
Volume: 26
Issue: 6
Pages: 1022-1031
ISSN: 0885-3185 (ISSN-L)
1531-8257
DOI: 10.1002/mds.23664
OpenAlex: W2020996348
Cited by: 423
References: 20
FWCI: 16.83
Type: journal article
Language: en
Open access: green
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 26 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page: CoChat. (2026). Citation check: Parkinson's disease: The quintessential neuropsychiatric disorder. https://app.cochat.ai/papers/10.1002/mds.23664
The paper: Weintraub, D., & Burn, D. J. (2011). Parkinson's disease: The quintessential neuropsychiatric disorder. Movement Disorders. https://doi.org/10.1002/mds.23664

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Parkinson's disease: The quintessential neuropsychiatric disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

How to cite

Data sources